First Real-World, Randomized, Sham-Controlled Clinical Trial of 2-Hour External Trigeminal Nerve Stimulation (e-TNS) in Finds That the e-TNS CEFALY Device Is Effective in Treating Acute Migraine Pain ...
DARIEN, Conn., June 7, 2022 /PRNewswire/ -- As Migraine and Headache Awareness Month kicks off, CEFALY Technology is celebrating its 8 th anniversary in the United States and a major milestone: 2 ...
DARIEN, Conn., Aug. 9, 2023 /PRNewswire/ -- Medical device maker CEFALY Technology will present findings from the TEAM (a phase 3 randomized, double-blind, sham-controlled Trial of e-TNS for the Acute ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback